• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PACS2/CPT1A/DHODH信号通路促进糖尿病性心肌病中的心肌细胞铁死亡。

PACS2/CPT1A/DHODH signaling promotes cardiomyocyte ferroptosis in diabetic cardiomyopathy.

作者信息

Xiang Hong, Lyu Qi, Chen Shuhua, Ouyang Jie, Xiao Di, Liu Quanjun, Long HaiJiao, Zheng Xinru, Yang Xiaoping, Lu Hongwei

机构信息

Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy, School of Medicine, Hunan Normal University, Changsha, Hunan, China.

Center for Experimental Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.

出版信息

Cardiovasc Diabetol. 2024 Dec 4;23(1):432. doi: 10.1186/s12933-024-02514-6.

DOI:10.1186/s12933-024-02514-6
PMID:39633391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11619700/
Abstract

OBJECTIVES

The pathophysiology of diabetic cardiomyopathy (DCM) is a phenomenon of great interest, but its clinical problems have not yet been effectively addressed. Recently, the mechanism of ferroptosis in the pathophysiology of various diseases, including DCM, has attracted widespread attention. Here, we explored the role of PACS2 in ferroptosis in DCM through its downregulation of PACS2 expression.

METHODS AND RESULTS

Cardiomyocytes were treated with high glucose and palmitic acid (HGPA), and the detection of cardiomyocyte iron ions, lipid peroxides, and reactive oxygen species (ROS) revealed clear ferroptosis during these treatments. Silencing PACS2 downregulated CPT1A expression and upregulated DHODH expression significantly, reversing HGPA-induced ferroptosis. Further silencing of PACS2 with a CPT1A agonist exacerbated cardiomyocyte ferroptosis while promoting mitochondrial damage in cardiomyocytes. Using a mouse model of type 2 diabetes induced by streptozotocin (STZ) and a high-fat diet (HFD), we found that PACS2 deletion reversed these treatment-induced increases in cellular iron ions, impaired cardiac function, mitochondrial damage and ferroptosis in cardiac muscle tissues.

CONCLUSIONS

The PACS2/CPT1A/DHODH signalling pathway may be involved in ferroptosis in DCM by regulating cardiomyocyte mitochondrial function.

摘要

目的

糖尿病性心肌病(DCM)的病理生理学是一个备受关注的现象,但其临床问题尚未得到有效解决。近年来,包括DCM在内的各种疾病病理生理学中的铁死亡机制引起了广泛关注。在此,我们通过下调PACS2表达来探讨PACS2在DCM铁死亡中的作用。

方法与结果

用高糖和棕榈酸(HGPA)处理心肌细胞,对心肌细胞铁离子、脂质过氧化物和活性氧(ROS)的检测显示,在这些处理过程中存在明显的铁死亡。沉默PACS2可显著下调CPT1A表达并上调DHODH表达,逆转HGPA诱导的铁死亡。用CPT1A激动剂进一步沉默PACS2会加剧心肌细胞铁死亡,同时促进心肌细胞的线粒体损伤。使用链脲佐菌素(STZ)和高脂饮食(HFD)诱导的2型糖尿病小鼠模型,我们发现缺失PACS2可逆转这些处理诱导的心肌组织中细胞铁离子增加、心脏功能受损、线粒体损伤和铁死亡。

结论

PACS2/CPT1A/DHODH信号通路可能通过调节心肌细胞线粒体功能参与DCM的铁死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/3b40d6443ff8/12933_2024_2514_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/34cfc919da42/12933_2024_2514_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/cce22e34d4ae/12933_2024_2514_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/a32e900ef083/12933_2024_2514_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/00c52b71de2a/12933_2024_2514_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/151b86e00a8c/12933_2024_2514_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/559bb389d41b/12933_2024_2514_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/de97d0fc1ec3/12933_2024_2514_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/3b40d6443ff8/12933_2024_2514_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/34cfc919da42/12933_2024_2514_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/cce22e34d4ae/12933_2024_2514_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/a32e900ef083/12933_2024_2514_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/00c52b71de2a/12933_2024_2514_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/151b86e00a8c/12933_2024_2514_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/559bb389d41b/12933_2024_2514_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/de97d0fc1ec3/12933_2024_2514_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fa/11619700/3b40d6443ff8/12933_2024_2514_Fig8_HTML.jpg

相似文献

1
PACS2/CPT1A/DHODH signaling promotes cardiomyocyte ferroptosis in diabetic cardiomyopathy.PACS2/CPT1A/DHODH信号通路促进糖尿病性心肌病中的心肌细胞铁死亡。
Cardiovasc Diabetol. 2024 Dec 4;23(1):432. doi: 10.1186/s12933-024-02514-6.
2
Piezo1 deletion mitigates diabetic cardiomyopathy by maintaining mitochondrial dynamics via ERK/Drp1 pathway.Piezo1基因缺失通过ERK/Drp1信号通路维持线粒体动力学,从而减轻糖尿病性心肌病。
Cardiovasc Diabetol. 2025 Mar 20;24(1):127. doi: 10.1186/s12933-025-02625-8.
3
ZIP7 contributes to the pathogenesis of diabetic cardiomyopathy by suppressing mitophagy in mouse hearts.ZIP7 通过抑制小鼠心脏中的线粒体自噬来促进糖尿病心肌病的发病机制。
Cardiovasc Diabetol. 2024 Nov 7;23(1):399. doi: 10.1186/s12933-024-02499-2.
4
Fibroblast growth factor 21 improves diabetic cardiomyopathy by inhibiting ferroptosis via ferritin pathway.成纤维细胞生长因子 21 通过铁蛋白途径抑制铁死亡改善糖尿病心肌病。
Cardiovasc Diabetol. 2024 Nov 2;23(1):394. doi: 10.1186/s12933-024-02469-8.
5
Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis.心肌细胞 LGR6 通过调节线粒体生物发生缓解糖尿病心肌病中的铁死亡。
Metabolism. 2024 Oct;159:155979. doi: 10.1016/j.metabol.2024.155979. Epub 2024 Jul 20.
6
Downregulation of HSPB1 and MGST1 Promotes Ferroptosis and Impacts Immune Infiltration in Diabetic Cardiomyopathy.HSPB1和MGST1的下调促进铁死亡并影响糖尿病心肌病中的免疫浸润。
Cardiovasc Toxicol. 2025 May;25(5):719-734. doi: 10.1007/s12012-025-09982-6. Epub 2025 Mar 7.
7
Cholesterol 25-hydroxylase prevents type 2 diabetes mellitus induced cardiomyopathy by alleviating cardiac lipotoxicity.胆固醇 25-羟化酶通过减轻心脏脂肪毒性预防 2 型糖尿病心肌病。
Biochim Biophys Acta Mol Basis Dis. 2024 Jun;1870(5):167158. doi: 10.1016/j.bbadis.2024.167158. Epub 2024 Apr 6.
8
Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD-SIRT3 pathway.Macrod1 通过调节 PARP1-NAD-SIRT3 通路抑制糖尿病心肌病。
Acta Pharmacol Sin. 2024 Jun;45(6):1175-1188. doi: 10.1038/s41401-024-01247-2. Epub 2024 Mar 8.
9
Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway.抑制CAV1通过激活NRF2/GCLC信号通路减少铁死亡,从而减轻糖尿病性心肌病。
Theranostics. 2025 Mar 31;15(11):4989-5006. doi: 10.7150/thno.107367. eCollection 2025.
10
Effect of NLRP3 gene knockdown on pyroptosis and ferroptosis in diabetic cardiomyopathy injury.NLRP3 基因敲低对糖尿病心肌病损伤中细胞焦亡和铁死亡的影响。
BMC Cardiovasc Disord. 2024 Jul 10;24(1):351. doi: 10.1186/s12872-024-04010-x.

引用本文的文献

1
PACS2/PKCα/NOX4 pathway damaged the renal vascular endothelial barrier by promoting ROS production in diabetic nephropathy mice.在糖尿病肾病小鼠中,PACS2/PKCα/NOX4通路通过促进活性氧生成破坏肾血管内皮屏障。
Mol Cell Biochem. 2025 Aug 7. doi: 10.1007/s11010-025-05363-3.
2
Ferroptosis in neurodegenerative diseases: potential mechanisms of exercise intervention.神经退行性疾病中的铁死亡:运动干预的潜在机制
Front Cell Dev Biol. 2025 Jun 30;13:1622544. doi: 10.3389/fcell.2025.1622544. eCollection 2025.
3
Molecular Insights into Oxidative-Stress-Mediated Cardiomyopathy and Potential Therapeutic Strategies.

本文引用的文献

1
USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.USP28 作为糖尿病心脏中线粒体形态和功能缺陷及心脏功能障碍的关键抑制因子。
Circulation. 2024 Feb 27;149(9):684-706. doi: 10.1161/CIRCULATIONAHA.123.065603. Epub 2023 Nov 23.
2
17β-oestradiol inhibits ferroptosis in the hippocampus by upregulating DHODH and further improves memory decline after ovariectomy.17β-雌二醇通过上调 DHODH 抑制海马铁死亡,进而改善去卵巢后记忆下降。
Redox Biol. 2023 Jun;62:102708. doi: 10.1016/j.redox.2023.102708. Epub 2023 Apr 23.
3
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development.
氧化应激介导的心肌病的分子见解及潜在治疗策略
Biomolecules. 2025 May 6;15(5):670. doi: 10.3390/biom15050670.
4
Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis.基于生物信息学分析探索糖尿病性心肌病中血管生成的关键靶分子。
Front Endocrinol (Lausanne). 2025 Apr 17;16:1561142. doi: 10.3389/fendo.2025.1561142. eCollection 2025.
5
DNA-PKcs-Driven YAP1 Phosphorylation and Nuclear Translocation: a Key Regulator of Ferroptosis in Hyperglycemia-Induced Cardiac Dysfunction in Type 1 Diabetes.DNA依赖蛋白激酶催化亚基(DNA-PKcs)驱动的Yes相关蛋白1(YAP1)磷酸化与核转位:1型糖尿病高血糖诱导心脏功能障碍中细胞铁死亡的关键调节因子
Adv Sci (Weinh). 2025 Apr 25:e2412698. doi: 10.1002/advs.202412698.
6
Hyperglycemia-induced DNA damage response activates DNA-PK complex to promote endothelial ferroptosis in type 2 diabetic cardiomyopathy.高血糖诱导的DNA损伤反应激活DNA-PK复合物以促进2型糖尿病心肌病中的内皮细胞铁死亡。
Theranostics. 2025 Mar 19;15(10):4507-4525. doi: 10.7150/thno.109514. eCollection 2025.
线粒体肉碱棕榈酰转移酶1A:结构、功能及药物开发基础的见解
Front Pharmacol. 2023 Mar 23;14:1160440. doi: 10.3389/fphar.2023.1160440. eCollection 2023.
4
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment.GPX4:脂质氧化、铁死亡、疾病和治疗的枢纽。
Biochim Biophys Acta Rev Cancer. 2023 May;1878(3):188890. doi: 10.1016/j.bbcan.2023.188890. Epub 2023 Mar 29.
5
FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner.FUNDC1 通过一种依赖于线粒体自噬的方式与 GPx4 相互作用,从而控制肝脏的铁死亡和纤维性损伤。
J Adv Res. 2024 Jan;55:45-60. doi: 10.1016/j.jare.2023.02.012. Epub 2023 Feb 23.
6
AKT/PACS2 Participates in Renal Vascular Hyperpermeability by Regulating Endothelial Fatty Acid Oxidation in Diabetic Mice.AKT/PACS2通过调节糖尿病小鼠的内皮脂肪酸氧化参与肾血管高通透性。
Front Pharmacol. 2022 Jul 5;13:876937. doi: 10.3389/fphar.2022.876937. eCollection 2022.
7
Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane AMPK/NRF2 pathways.铁死亡对糖尿病性心肌病至关重要,而萝卜硫素通过AMPK/NRF2信号通路可预防铁死亡。
Acta Pharm Sin B. 2022 Feb;12(2):708-722. doi: 10.1016/j.apsb.2021.10.005. Epub 2021 Oct 15.
8
Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy.谷胱甘肽耗竭在癌症治疗中的应用:增强基于 ROS 的治疗、铁死亡和化疗。
Biomaterials. 2021 Oct;277:121110. doi: 10.1016/j.biomaterials.2021.121110. Epub 2021 Aug 30.
9
The Attenuation of Diabetic Nephropathy by Annexin A1 via Regulation of Lipid Metabolism Through the AMPK/PPARα/CPT1b Pathway.膜联蛋白A1通过AMPK/PPARα/CPT1b途径调节脂质代谢减轻糖尿病肾病
Diabetes. 2021 Oct;70(10):2192-2203. doi: 10.2337/db21-0050. Epub 2021 Jun 8.
10
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.DHODH 介导的铁死亡防御是癌症的一个可靶向弱点。
Nature. 2021 May;593(7860):586-590. doi: 10.1038/s41586-021-03539-7. Epub 2021 May 12.